DNA Vaccines Market - Forecast(2019 - 2024)

Report Code: HCR 0280 Report Format: PDF + Excel (Delivery in 48 Hrs)
Vaccines are antigenic substances prepared from the causative agent of a disease or a synthetic substitute of it and generally used to impart immunity against one or several diseases. DNA vaccines are composed of deoxyribonucleic acid, which encodes antigens and stimulate a wider range of immune responses in the body with few side effects. DNA vaccines are a result of technological progression in biotechnology and gene delivery systems. Clinical trials of some DNA vaccines have shown promising results in treatment of several types of cancers like metastatic melanoma, prostate carcinoma, pancreatic cancer, and other solid tumors.

Factors driving global demand for DNA vaccine market are increasing awareness amongst health professional, fewer side effects, ease of development and lower cost, constant progress in biotechnology and conventional therapy failure in treatment of most infectious diseases.

This report provides information on DNA vaccine market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to DNA vaccine market.
 
DNA Vaccines Market

Globally, emerging technologies have taken healthcare closer to patients, DNA vaccines is one among these technology. They mainly use immunological pathways, which are difficult to achieve by other technologies. North America, Europe and other developed economies have good market for DNA vaccines due to their well-equipped healthcare infrastructure, a prominent research and development activities in the field of DNA vaccines, awareness among healthcare physicians on treatment options and percentage of people covered under healthcare insurance. APAC region has a growing demand for DNA vaccines due to increasing awareness on availability of new treatment options and increased focus on research and development activities.

This report identifies global DNA vaccine market based on different types and regional market as follows:
  • DNA vaccine market is segmented based on types. There are two main types’ human DNA vaccines and animals DNA vaccines, there are more than 100 products under clinical trial for different diseases in humans including HIV infection, cancer and infectious diseases etc. and three animal DNA vaccines are approved for veterinary use
  • This report is further segmented based on potential markets for DNA vaccines. A detailed analysis by region – United States, Europe, Asia-Pacific (APAC) and Rest of the World (RoW), has been provided in this report

This report looks into all the major companies operating in the DNA vaccines. Some of the major companies’ profiles are as follows:
  • Inovio Biomedical Corp.
  • Merck & Co.
  • Mitsubishi Tanabe
  • Dendreon Corporation
  • Astellas Pharma
1. DNA Vaccines Market - Overview
1.1. Definitions and Scope
2. DNA Vaccines Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. DNA Vaccines Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. DNA Vaccines Market – Startup companies Scenario Premium
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. DNA Vaccines Market – Industry Market Entry Scenario Premium
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. DNA Vaccines Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. DNA Vaccines Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
7.4. Suppliers and distributors Market Share
8. DNA Vaccines Market – By type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Application Revenue and Trend Research
8.3. Product Segment Analysis
8.3.1. DNA vaccines for humans
8.3.2. DNA vaccines for animals
9. DNA Vaccines - By Geography (Market Size -$Million / $Billion)
9.1. DNA Vaccines Market - North America Segment Research
9.2. North America Market Research (Million / $Billion)
9.2.1. Segment type Size and Market Size Analysis 
9.2.2. Revenue and Trends
9.2.3. Application Revenue and Trends by type of Application
9.2.4. Company Revenue and Product Analysis
9.2.5. North America Product type and Application Market Size
9.2.5.1. U.S.
9.2.5.2. Canada 
9.2.5.3. Mexico 
9.2.5.4. Rest of North America
9.3. DNA Vaccines - South America Segment Research
9.4. South America Market Research (Market Size -$Million / $Billion)
9.4.1. Segment type Size and Market Size Analysis 
9.4.2. Revenue and Trends
9.4.3. Application Revenue and Trends by type of Application
9.4.4. Company Revenue and Product Analysis
9.4.5. South America Product type and Application Market Size
9.4.5.1. Brazil  
9.4.5.2. Venezuela
9.4.5.3. Argentina
9.4.5.4. Ecuador
9.4.5.5. Peru
9.4.5.6. Colombia 
9.4.5.7. Costa Rica
9.4.5.8. Rest of South America
9.5. DNA Vaccines - Europe Segment Research
9.6. Europe Market Research (Market Size -$Million / $Billion)
9.6.1. Segment type Size and Market Size Analysis 
9.6.2. Revenue and Trends
9.6.3. Application Revenue and Trends by type of Application
9.6.4. Company Revenue and Product Analysis
9.6.5. Europe Segment Product type and Application Market Size
9.6.5.1. U.K  
9.6.5.2. Germany 
9.6.5.3. Italy 
9.6.5.4. France
9.6.5.5. Netherlands
9.6.5.6. Belgium
9.6.5.7. Spain
9.6.5.8. Denmark
9.6.5.9. Rest of Europe
9.7. DNA Vaccines – APAC Segment Research
9.8. APAC Market Research (Market Size -$Million / $Billion)
9.8.1. Segment type Size and Market Size Analysis 
9.8.2. Revenue and Trends
9.8.3. Application Revenue and Trends by type of Application
9.8.4. Company Revenue and Product Analysis
9.8.5. APAC Segment – Product type and Application Market Size
9.8.5.1. China 
9.8.5.2. Australia
9.8.5.3. Japan 
9.8.5.4. South Korea
9.8.5.5. India
9.8.5.6. Taiwan
9.8.5.7. Malaysia
10. DNA Vaccines Market - Entropy
10.1. New product launches
10.2. M&A's, collaborations, JVs and partnerships
11. DNA Vaccines Market – Industry / Segment Competition landscape Premium
11.1. Market Share Analysis
11.1.1. Market Share by Country- Top companies
11.1.2. Market Share by Region- Top 10 companies
11.1.3. Market Share by type of Application – Top 10 companies
11.1.4. Market Share by type of Product / Product category- Top 10 companies
11.1.5. Market Share at global level- Top 10 companies
11.1.6. Best Practises for companies
12. DNA Vaccines Market – Key Company List by Country Premium
13. DNA Vaccines Market Company Analysis
13.1. Market Share, Company Revenue, Products, M&A, Developments
13.2. Inovio Biomedical Corp.
13.3. Merck & Co.
13.4. Mitsubishi Tanabe
13.5. Dendreon Corporation
13.6. ASTELLAS PHARMA
13.7. Dynavax Technologies
13.8. Sanofi
13.9. Tekmira Pharmaceuticals
13.10. GlaxoSmithKline Corp
13.11. Protein Sciences Corp.
13.12. Company 11
13.13. Company 12
13.14. Company 13 and more
"*Financials would be provided on a best efforts basis for private companies"
14. DNA Vaccines Market - Appendix
14.1. Abbreviations
14.2. Sources
15. DNA Vaccines Market - Methodology
15.1. Research Methodology
15.1.1. Company Expert Interviews
15.1.2. Industry Databases
15.1.3. Associations
15.1.4. Company News
15.1.5. Company Annual Reports
15.1.6. Application Trends
15.1.7. New Products and Product database
15.1.8. Company Transcripts
15.1.9. R&D Trends
15.1.10. Key Opinion Leaders Interviews
15.1.11. Supply and Demand Trends
List of Tables

Table 1: DNA Vaccines Market Overview 2019-2024
Table 2: DNA Vaccines Market Leader Analysis 2018-2019 (US$)
Table 3: DNA Vaccines Market Product Analysis 2018-2019 (US$)
Table 4: DNA Vaccines Market End User Analysis 2018-2019 (US$)
Table 5: DNA Vaccines Market Patent Analysis 2013-2018* (US$)
Table 6: DNA Vaccines Market Financial Analysis 2018-2019 (US$)
Table 7: DNA Vaccines Market Driver Analysis 2018-2019 (US$)
Table 8: DNA Vaccines Market Challenges Analysis 2018-2019 (US$)
Table 9: DNA Vaccines Market Constraint Analysis 2018-2019 (US$)
Table 10: DNA Vaccines Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: DNA Vaccines Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: DNA Vaccines Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: DNA Vaccines Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: DNA Vaccines Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: DNA Vaccines Market Value Chain Analysis 2018-2019 (US$)
Table 16: DNA Vaccines Market Pricing Analysis 2019-2024 (US$)
Table 17: DNA Vaccines Market Opportunities Analysis 2019-2024 (US$)
Table 18: DNA Vaccines Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: DNA Vaccines Market Supplier Analysis 2018-2019 (US$)
Table 20: DNA Vaccines Market Distributor Analysis 2018-2019 (US$)
Table 21: DNA Vaccines Market Trend Analysis 2018-2019 (US$)
Table 22: DNA Vaccines Market Size 2018 (US$)
Table 23: DNA Vaccines Market Forecast Analysis 2019-2024 (US$)
Table 24: DNA Vaccines Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26: DNA Vaccines Market By Type, Revenue & Volume, By DNA vaccines for humans, 2019-2024 ($)
Table 27: DNA Vaccines Market By Type, Revenue & Volume, By DNA vaccines for animals, 2019-2024 ($)
Table 28: North America DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 29: South america DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 30: Europe DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 31: APAC DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 32: Middle East & Africa DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 33: Russia DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 34: Israel DNA Vaccines Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 35: Top Companies 2018 (US$)DNA Vaccines Market, Revenue & Volume
Table 36: Product Launch 2018-2019DNA Vaccines Market, Revenue & Volume
Table 37: Mergers & Acquistions 2018-2019DNA Vaccines Market, Revenue & Volume


List of Figures

Figure 1: Overview of DNA Vaccines Market 2019-2024
Figure 2: Market Share Analysis for DNA Vaccines Market 2018 (US$)
Figure 3: Product Comparison in DNA Vaccines Market 2018-2019 (US$)
Figure 4: End User Profile for DNA Vaccines Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in DNA Vaccines Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in DNA Vaccines Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in DNA Vaccines Market 2018-2019
Figure 8: Ecosystem Analysis in DNA Vaccines Market 2018
Figure 9: Average Selling Price in DNA Vaccines Market 2019-2024
Figure 10: Top Opportunites in DNA Vaccines Market 2018-2019
Figure 11: Market Life Cycle Analysis in DNA Vaccines Market
Figure 12: GlobalBy TypeDNA Vaccines Market Revenue, 2019-2024 ($)
Figure 13: Global DNA Vaccines Market - By Geography
Figure 14: Global DNA Vaccines Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 15: Global DNA Vaccines Market CAGR, By Geography, 2019-2024 (%)
Figure 16: North America DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 17: US DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 18: US GDP and Population, 2018-2019 ($)
Figure 19: US GDP – Composition of 2018, By Sector of Origin
Figure 20: US Export and Import Value & Volume, 2018-2019 ($)
Figure 21: Canada DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 22: Canada GDP and Population, 2018-2019 ($)
Figure 23: Canada GDP – Composition of 2018, By Sector of Origin
Figure 24: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Mexico DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 26: Mexico GDP and Population, 2018-2019 ($)
Figure 27: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 28: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 29: South America DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 30: Brazil DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 31: Brazil GDP and Population, 2018-2019 ($)
Figure 32: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 33: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 34: Venezuela DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 35: Venezuela GDP and Population, 2018-2019 ($)
Figure 36: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 37: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Argentina DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 39: Argentina GDP and Population, 2018-2019 ($)
Figure 40: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 41: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Ecuador DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 43: Ecuador GDP and Population, 2018-2019 ($)
Figure 44: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 45: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Peru DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 47: Peru GDP and Population, 2018-2019 ($)
Figure 48: Peru GDP – Composition of 2018, By Sector of Origin
Figure 49: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Colombia DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 51: Colombia GDP and Population, 2018-2019 ($)
Figure 52: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 53: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Costa Rica DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 55: Costa Rica GDP and Population, 2018-2019 ($)
Figure 56: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 57: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Europe DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 59: U.K DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 60: U.K GDP and Population, 2018-2019 ($)
Figure 61: U.K GDP – Composition of 2018, By Sector of Origin
Figure 62: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 63: Germany DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 64: Germany GDP and Population, 2018-2019 ($)
Figure 65: Germany GDP – Composition of 2018, By Sector of Origin
Figure 66: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Italy DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 68: Italy GDP and Population, 2018-2019 ($)
Figure 69: Italy GDP – Composition of 2018, By Sector of Origin
Figure 70: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 71: France DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 72: France GDP and Population, 2018-2019 ($)
Figure 73: France GDP – Composition of 2018, By Sector of Origin
Figure 74: France Export and Import Value & Volume, 2018-2019 ($)
Figure 75: Netherlands DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 76: Netherlands GDP and Population, 2018-2019 ($)
Figure 77: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 78: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Belgium DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 80: Belgium GDP and Population, 2018-2019 ($)
Figure 81: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 82: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Spain DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 84: Spain GDP and Population, 2018-2019 ($)
Figure 85: Spain GDP – Composition of 2018, By Sector of Origin
Figure 86: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Denmark DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 88: Denmark GDP and Population, 2018-2019 ($)
Figure 89: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 90: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 91: APAC DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 92: China DNA Vaccines Market Value & Volume, 2019-2024
Figure 93: China GDP and Population, 2018-2019 ($)
Figure 94: China GDP – Composition of 2018, By Sector of Origin
Figure 95: China Export and Import Value & Volume, 2018-2019 ($)DNA Vaccines Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 96: Australia DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 97: Australia GDP and Population, 2018-2019 ($)
Figure 98: Australia GDP – Composition of 2018, By Sector of Origin
Figure 99: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 100: South Korea DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 101: South Korea GDP and Population, 2018-2019 ($)
Figure 102: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 103: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 104: India DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 105: India GDP and Population, 2018-2019 ($)
Figure 106: India GDP – Composition of 2018, By Sector of Origin
Figure 107: India Export and Import Value & Volume, 2018-2019 ($)
Figure 108: Taiwan DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 109: Taiwan GDP and Population, 2018-2019 ($)
Figure 110: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 111: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Malaysia DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 113: Malaysia GDP and Population, 2018-2019 ($)
Figure 114: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 115: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Hong Kong DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 117: Hong Kong GDP and Population, 2018-2019 ($)
Figure 118: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 119: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Middle East & Africa DNA Vaccines Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 121: Russia DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 122: Russia GDP and Population, 2018-2019 ($)
Figure 123: Russia GDP – Composition of 2018, By Sector of Origin
Figure 124: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 125: Israel DNA Vaccines Market Value & Volume, 2019-2024 ($)
Figure 126: Israel GDP and Population, 2018-2019 ($)
Figure 127: Israel GDP – Composition of 2018, By Sector of Origin
Figure 128: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Entropy Share, By Strategies, 2018-2019* (%)DNA Vaccines Market
Figure 130: Developments, 2018-2019*DNA Vaccines Market
Figure 131: Company 1 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 132: Company 1 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 133: Company 1 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 134: Company 2 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 135: Company 2 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 136: Company 2 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 137: Company 3 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 138: Company 3 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 139: Company 3 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 140: Company 4 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 141: Company 4 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 142: Company 4 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 143: Company 5 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 144: Company 5 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 145: Company 5 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 146: Company 6 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 147: Company 6 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 148: Company 6 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 149: Company 7 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 150: Company 7 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 151: Company 7 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 152: Company 8 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 153: Company 8 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 154: Company 8 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 155: Company 9 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 156: Company 9 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 157: Company 9 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 158: Company 10 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 159: Company 10 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 160: Company 10 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 161: Company 11 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 162: Company 11 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 163: Company 11 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 164: Company 12 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 165: Company 12 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 166: Company 12 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 167: Company 13 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 168: Company 13 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 169: Company 13 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 170: Company 14 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 171: Company 14 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 172: Company 14 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)
Figure 173: Company 15 DNA Vaccines Market Net Revenue, By Years, 2018-2019* ($)
Figure 174: Company 15 DNA Vaccines Market Net Revenue Share, By Business segments, 2018 (%)
Figure 175: Company 15 DNA Vaccines Market Net Sales Share, By Geography, 2018 (%)